Baudouin Hue
Partner @ Karista
Paris, France
Baudouin Hue is a seed investor at Karista in Paris focused on Medical and Health Care. Baudouin Hue - Partner @ Karista
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Baudouin Hue invests in
Stages Baudouin Hue invests in
Countries Baudouin Hue invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 3 (60%)
- Health Care 3 (60%)
- Medical Device 3 (60%)
- Biotechnology 2 (40%)
- mHealth 1 (20%)
Stage
- Seed 2 (40%)
- Series A 2 (40%)
- Series B 1 (20%)
Country
- France 3 (60%)
- Belgium 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Brightflow
|
Brightflow operates as a medical device startup. | $18.2M / Series A / Sep 10, 2024 | |
| Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of connected cardiac prostheses. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of an artificial intelligence module and determines the criticality of each alerttaking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform. | $23M / Series A / Apr 27, 2022 | ||
| moveUP develops and commercialise digital therapeutics solutions. Its closed loop system enables high compliance, better outcome and satisfaction. It uses continuously collected data to directly personalise the treatment of the patient. Its first therapy treats orthopaedic patients undergoing a joint surgery. It has CE medical device & ISO13485 certification. | $4.5M / Seed / May 24, 2021 | ||
| Implicity is a developer of a Saas-based remote monitoring platform designed to provide smart monitoring of connected cardiac prostheses. The company's platform sorts and summarizes data of patients with connected pacemakers and defibrillators with the help of an artificial intelligence module and determines the criticality of each alerttaking into account the medical context of the patient, enabling cardiologists and healthcare professionals to automate the remote monitoring of their patients and get patients' telepulse on a single platform. | $4.5M / Seed / Mar 14, 2019 | ||
| Pherecydes Pharma operator of an innovative biotechnologies company created to develop personalized phage therapy to treat bacterial infections. The company develops bacteriophages against infections and launched multicenter European phage therapy trial to evaluate phage therapy on infected burn wounds, recognize bacterial target attached to itsouter membrane, inject genetic material and reproduce in the host to make new phages that get out and repeat the same cycle, enabling doctors to detect and treat people and their environment against a large range of biothreat agents, including multi-resistant, emergent or previously uncharacterized bacteria. | $10.7M / Series B / Jan 16, 2018 |
Co-Investors
About Karista
Karista is an early-stage venture capital firm created in 2001. We funded 90+ companies over the past two decades and support tomorrow’s game changers in the field of Health, Digital, Tech, and NewSpace. We have always worked to provide more than cash and partnered with entrepreneurs whom we share a common vision with.
Karista Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Agathe Testu
Secretary General - RCCI
|
|||
|
Baudouin Hue
Partner
|
|||
Benjamin Zerbib
Investment Director
|
|||
Catherine Boule
Managing Partner
|
|||
Elodie Feraille
Management Assistant
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Baudouin Hue invest in?
Baudouin Hue invests primarily in Medical, Health Care and Medical Device startups, most often at Seed and Series A stage. Most of the 5 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Baudouin Hue?
Public channels for Baudouin Hue include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Baudouin Hue last invest?
The most recent investment recorded for Baudouin Hue closed in Sep 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
